| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.91B | 13.98B | 14.55B | 11.19B | 13.68B | 15.36B |
| Gross Profit | 10.71B | 14.45B | 14.50B | 11.14B | 13.63B | 15.29B |
| EBITDA | 2.04B | 3.05B | 2.76B | 179.00M | 1.97B | 2.92B |
| Net Income | 1.65B | 2.42B | 2.34B | 773.00M | 1.39B | 1.87B |
Balance Sheet | ||||||
| Total Assets | 69.12B | 63.48B | 74.03B | 61.56B | 64.51B | 71.91B |
| Cash, Cash Equivalents and Short-Term Investments | 29.31B | 24.79B | 29.84B | 25.78B | 23.35B | 25.59B |
| Total Debt | 4.80B | 3.26B | 4.34B | 5.28B | 4.29B | 4.23B |
| Total Liabilities | 30.14B | 23.38B | 31.21B | 22.54B | 25.44B | 32.21B |
| Stockholders Equity | 38.98B | 40.10B | 42.82B | 39.02B | 39.07B | 39.71B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -5.59B | 6.82B | -951.00M | -990.00M | 2.05B |
| Operating Cash Flow | 0.00 | -5.48B | 6.92B | -42.00M | -721.00M | 2.28B |
| Investing Cash Flow | 0.00 | 963.00M | 1.04B | -346.00M | -587.00M | -52.00M |
| Financing Cash Flow | 0.00 | -3.69B | -1.96B | -596.00M | -1.32B | -652.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥42.55B | 6.25 | 7.66% | 5.47% | -1.80% | -1.02% | |
81 Outperform | ¥86.91B | 6.63 | ― | 5.75% | 10.85% | 30.77% | |
74 Outperform | ¥248.57B | 12.14 | 14.00% | 5.13% | 3.27% | -1.81% | |
71 Outperform | ¥50.24B | 10.12 | ― | 4.36% | 1.14% | -16.88% | |
71 Outperform | ¥71.70B | 12.60 | 9.22% | 6.15% | 7.45% | 45.25% | |
68 Neutral | ¥48.78B | 9.12 | ― | 4.86% | 6.40% | 41.18% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |